0
Diffuse Lung Disease |

Pulmonary Alveolar Proteinosis and Whole Lung Lavage in a Tertiary Center From Romania: A Study on Twenty Patients

Oana Deleanu; Ana Nebunoiu; Carolina Tarasova; Aneta Serbescu; Radu Stoica; Genoveva Cadar; Oana Arghir; Florin Mihaltan, MD
Author and Funding Information

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania


Chest. 2014;146(4_MeetingAbstracts):375A. doi:10.1378/chest.1993338
Text Size: A A A
Published online

Abstract

SESSION TITLE: Interstitial Lung Disease Posters II

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 29, 2014 at 01:30 PM - 02:30 PM

PURPOSE: We aimed to describe clinical features of a rare condition which determines an interstitial-like syndrome - pulmonar alveolar proteinosis (PAP), specific imagistic, pathologic findings and to describe our center’s experience in whole lung lavage (WLL), main PAP treatment accepted at this moment.

METHODS: We effectuated a retrospective analysis of all files from all admissions of patients with PAP from the period January 2007- December 2012 in a tertiar pneumology center in Romania; data where noted and analyzed.

RESULTS: A number of 20 patients (13 males, sex ratio 1.86:1) where identified with PAP during the noted period. Mean age at first evaluation was 41.9±16.5 years, 4 patients had exposure to respiratory noxes, 4 were smokers, 4 former smokers (all women were non-smokers). Diagnostic was made in all patients using broncho-alveolar lavage. Descriptive analysis of the group was made concerning clinical, paraclinical and evolution aspects. From 20 patients, 14 effectuated whole lung lavage (WLL) at least one time during the 6 years period (minimum 1, maximum 6, mean 2.64±1.4 WLL/patient), 2 patients had a contraindication of WLL and 4 patients did not meet the criteria for WLL. A total of 36 WLL were performed (period between two consecutive WLL was 4,9±4,1 months). Complications due to WLL were severe postprocedural hypoxemia in 2 cases and pneumotorax in one case. When analysing the differences between those having indication of WLL (including those in whom WLL wasn’t performed due to contraindication), the only significant difference that we found was that patients with indication of WLL had lower values in procentual forced vital capacity (FVC%), p=0.01 and procentual forced expiratory volume in 1 second (FEV1%), p=0.008. One spontan remission and one death due to respiratory insuficiency were noted.

CONCLUSIONS: This is, to our knowledge, an analysis of the biggest cohort of PAP patients in Romania.

CLINICAL IMPLICATIONS: Study revealed that in the absence of precise indications for WLL, the clinical presentation of the patient and the severity of restriction as objective paraclinical method are the main findings that dictate the need of WLL.

DISCLOSURE: The following authors have nothing to disclose: Oana Deleanu, Ana Nebunoiu, Carolina Tarasova, Aneta Serbescu, Radu Stoica, Genoveva Cadar, Oana Arghir, Florin Mihaltan

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543